These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2465857)

  • 1. The interferons. A clinician's view.
    Landow RK
    Dermatol Clin; 1988 Oct; 6(4):569-74. PubMed ID: 2465857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferons. New additions and indications for use.
    Stadler R; Ruszczak Z
    Dermatol Clin; 1993 Jan; 11(1):187-99. PubMed ID: 7679614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interferon: therapy in patients with cutaneous malignant melanoma in adjuvant setting].
    Wcisło G; Szczylik C
    Pol Merkur Lekarski; 2003 Jul; 15(85):5-8. PubMed ID: 14593950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A potential predictive marker for response to interferon in malignant melanoma.
    Wild PJ; Meyer S; Landthaler M; Hofstaedter F; Bosserhoff AK
    J Dtsch Dermatol Ges; 2007 Jun; 5(6):456-9. PubMed ID: 17537037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokines in dermatology.
    Holman DM; Kalaaji AN
    J Drugs Dermatol; 2006 Jun; 5(6):520-4. PubMed ID: 16774103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adjuvant interferon treatment of melanoma].
    Török L
    Magy Onkol; 2003; 47(1):105-7. PubMed ID: 12704462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant melanoma and other second cutaneous malignancies in cutaneous T-cell lymphoma. The influence of additional therapy after total skin electron beam radiation.
    Licata AG; Wilson LD; Braverman IM; Feldman AM; Kacinski BM
    Arch Dermatol; 1995 Apr; 131(4):432-5. PubMed ID: 7726585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photofrin-mediated photodynamic therapy for treatment of aggressive head and neck nonmelanomatous skin tumors in elderly patients.
    Gayl Schweitzer V
    Laryngoscope; 2001 Jun; 111(6):1091-8. PubMed ID: 11404627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Langerhans cells in benign, premalignant and malignant skin lesions of renal transplant recipients and the effect of retinoid therapy.
    Gibson GE; O'Grady A; Kay EW; Leader M; Murphy GM
    J Eur Acad Dermatol Venereol; 1998 Mar; 10(2):130-6. PubMed ID: 9553909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon (IFN) for malignant melanoma unmasking an autoimmune hepatitis.
    Lebiedz P; August C; Domschke W; Schmidt HH
    Eur J Intern Med; 2009 Jan; 20(1):e3-4. PubMed ID: 19237078
    [No Abstract]   [Full Text] [Related]  

  • 11. Interferon in the treatment of cutaneous T-cell lymphoma.
    Olsen EA; Bunn PA
    Hematol Oncol Clin North Am; 1995 Oct; 9(5):1089-107. PubMed ID: 8522486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant treatment of malignant melanoma: where are we?
    Ascierto PA; Scala S; Ottaiano A; Simeone E; de Michele I; Palmieri G; Castello G
    Crit Rev Oncol Hematol; 2006 Jan; 57(1):45-52. PubMed ID: 15990330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interferons: physiology, pharmacology and pharmacotherapeutic perspectives].
    Billiau A
    J Pharmacol; 1983; 14 Suppl 3():105-16. PubMed ID: 6200731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The present status of the multidisciplinary treatment of malignant melanoma].
    Ishihara K; Hayasaka K; Ikegawa S; Kageshita T
    Gan No Rinsho; 1985 Jul; 31(9 Suppl):1073-8. PubMed ID: 4057571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of interferon alfa as adjuvant therapy for advanced cutaneous melanoma: the need for more evidence.
    Kimyai-Asadi A; Usman A
    J Am Acad Dermatol; 2000 Oct; 43(4):708-11. PubMed ID: 11004636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant interferon in melanoma - a resurrection?
    Middleton MR; Thatcher N
    Br J Cancer; 2001 May; 84(9):1141-2. PubMed ID: 11336461
    [No Abstract]   [Full Text] [Related]  

  • 17. Potentiation of interferon action.
    Schwarz LA; Fleischmann WR
    Tex Rep Biol Med; 1981-1982; 41():298-306. PubMed ID: 6184817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in the treatment of basal cell carcinoma: the promise of pharmacologic therapy.
    Vander Straten M; Lee P; Weitzul S; Cockerell CJ; Tyring SK
    Adv Dermatol; 2000; 16():299-318; discussion 319. PubMed ID: 11094632
    [No Abstract]   [Full Text] [Related]  

  • 19. [Indications for interferon in dermatology].
    Desmons F
    LARC Med; 1982 Nov; 2(10):895-8. PubMed ID: 6188013
    [No Abstract]   [Full Text] [Related]  

  • 20. [Possibilities and limits of the use of interferons in the clinic].
    Ludwig CU
    Schweiz Med Wochenschr; 1989 Nov; 119(44):1539-43. PubMed ID: 2479977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.